Glycemic Responses and of the Autonomic Cardiac Function in Diabetes Type-2 Women Post Resistance Exercise
1 other identifier
interventional
12
0 countries
N/A
Brief Summary
The aim of this study was to investigate and correlate the glucose responses and VFC 24 hours after resistance exercise (RE) sessions at different intensities in women with type 2 diabetes (DM-2). Twelve women with DM-2 were invited to perform by one week in randomized order, two weeks interventions with experimental sessions: Session Control (CONT) without conducting RE, RE session (40% or 80% of one maximum repetition - 1RM) on day 2 and day 3 was observed the effect of the length of RE session by 11h. After that, initiated the experimental sessions, where after each of the analysis of glucose 24h by continuous monitoring system of glucose was performed, considering breakfast, lunch, dinner and sleep, and analysis performed of the RR series by a period of 48h. During control sessions, the subjects were seated comfortably for 40min and RE sessions, 40%1RM and 80%1RM, were performed in medium circuit 3 sets with 16 and 8 replications and recovery range between 60 exercises and 90seg , respectively, and between the circuits 120sec. It was observed that the concentration of glucose in the period of 24h after the session has been reduced to 40% 1RM vs. CONT and 80%1RM. Hyperglycemia was prevalent in the period 34h of the sessions CONT and 80%1RM, respectively , being different from the session 40%1RM. In postprandial times, shorter hyperglycemia was found in the session to 40% 1RM vs. CONT and 80% 1RM after breakfast, lunch and dinner. At the time of sleep, less time in hyperglycemia was found between sessions of 40% 1RM vs. 80% 1RM. Significant correlations (p \<0.01) were found between glucose 24h with cardiac autonomic RRi variables, HF, LF and reason LF:HF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus
Started Nov 2014
Shorter than P25 for not_applicable diabetes-mellitus
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 12, 2015
CompletedFirst Posted
Study publicly available on registry
January 1, 2016
CompletedJanuary 1, 2016
December 1, 2015
9 months
December 12, 2015
December 30, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concentration of glucose and hyperglycemia prevalence
Acute bout of resistance exercise at 40% 1RM (low intensity) reduced glucose concentrations and the prevalence of hyperglycemia in 73.1 ± 37.7% and 68.4 ± 51.1% compared to the sessions CONT40% and resistance exercise 80% 1RM (high intensity) respectively in 24h from each session.
24 hours
Secondary Outcomes (2)
Heart Rate Variability
24 hours
Correlation between heart rate variability and glucose 24 hours
24 hours
Study Arms (2)
Resistance Exercise Low intensity
OTHERDay 1 (Control Session) Day 2 (Resistance Exercise) Day 3 (Duration of effect)
Resistance Exercise High intensity
OTHERDay 1 (Control Session) Day 2 (Resistance Exercise) Day 3 (Duration of effect)
Interventions
Control Session Resistance exercise at different intensities (40%1RM or 80%1RM) Duration of effect
Eligibility Criteria
You may qualify if:
- Being female, diagnosed with type 2 diabetes (DM-2) and be clinically stable, and be aged between 40 and 60 years.
You may not qualify if:
- Make use of exogenous insulin
- Have morbid obesity (BMI\> 40 kg / m2)
- Provide uncompensated glucose and abnormalities in the electrocardiogram (ECG) at rest with suggestion of cardiac ischemia from above or below unevenness in the ST segment\> 2mm or reversal in T wave
- Presenting heart disease
- Proliferative diabetic retinopathy
- Severe autonomic neuropathy
- Any limb amputation
- Uncontrolled hypertension (systolic\> 160 mmHg and / or diastolic BP\> 100 mmHg)
- Diabetic nephropathy (albuminuria ≥ 14mg / L or\> 30mg / 24h) chronic renal failure (SBD, 2014; ADA, 2014)
- Osteo-myo-articular problems that limited the exercises and being a smoker.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Loumaíra Carvalho da Cruz
Universidade Federal do vale do São Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 12, 2015
First Posted
January 1, 2016
Study Start
November 1, 2014
Primary Completion
August 1, 2015
Study Completion
September 1, 2015
Last Updated
January 1, 2016
Record last verified: 2015-12
Data Sharing
- IPD Sharing
- Will not share